SCHEMBL13075786

SCHEMBL13075786

O=[N+]([O-])c1cc(Cl)cnc1N1CCNCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
MAPK1 P28482 1/20 0.52
HTT P42858 1/20 0.52
CHRNB2 P17787 2/20 0.48
CHRNA4 P43681 2/20 0.48
MAPT P10636 6/20 0.45
RECQL P46063 1/20 0.45
CHRNA1 P02708 1/20 0.43
CHRNA7 P36544 1/20 0.43
HRH4 Q9H3N8 2/20 0.43
HTR6 P50406 2/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
ADRB1 P08588 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL113861 0.99 ALDH1A1 (0.51) ALDH1A1MAPK1HTTCHRNB2CHRNA4
SCHEMBL29445495 0.85 ALDH1A1 (0.71) ALDH1A1MAPK1HTTMAPTLMNA
SCHEMBL9684591 0.84 ALDH1A1 (0.74) ALDH1A1MAPK1HTTMAPTRECQL
SCHEMBL29274242 0.83 ALDH1A1 (0.52) ALDH1A1MAPK1HTTMAPTRECQL
SCHEMBL2711422 0.83 CYP1A2 (0.58) ALDH1A1MAPK1HTTMAPTLMNA
SCHEMBL29274207 0.80 SMN1; SMN2 (0.60) ALDH1A1MAPK1HTTMAPTRECQL
SCHEMBL22587713 0.79 OPRK1 (0.50) ALDH1A1MAPK1HTTMAPTLMNA
SCHEMBL29445426 0.79 OPRK1 (0.50) ALDH1A1MAPK1HTTMAPTLMNA
SCHEMBL31013290 0.79 ALDH1A1 (0.51) ALDH1A1MAPK1HTTMAPTLMNA
SCHEMBL899662 0.77 CHRNB2 (0.50) CHRNB2CHRNA4CHRNA1CHRNA7HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424858-B1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2014-05-14 EP disclosed
US-8362249-B2 CXCR3 receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-29 US disclosed
WO-2010126851-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed
US-20100273781-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100273781-A1 CXCR3 RECEPTOR ANTAGONISTS CXCR3, CXCR1, CXCR2 ALDH1A1 1720/4885MAPK1 1970/4885HTT 4213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.